Immunohistochemistry was used to verify the expression of NDFIP2 in HCC, and the results showed that 58/84 (69%) of the samples had lower NDFIP2 expression in tumour tissues than in non-tumor tissues (Fig. 4D). The gene discussed is NDFIP2; the disease is neoplasm.